• 2023
  Walker MWG, Klompe SE, Zhang DJ, Sternberg SH, , Novel molecular requirements for CRISPR RNA-guided transposition., Nucleic Acids Res 2023 Apr; (): .
• 2023
  Lampe GD, King RT, Halpin-Healy TS, Klompe SE, Hogan MI, Vo PLH, Tang S, Chavez A, Sternberg SH, , Targeted DNA integration in human cells without double-strand breaks using CRISPR-associated transposases., Nat Biotechnol 2023 Mar; (): .
• 2023
  Gelsinger DR, Vo PLH, Klompe SE, Ronda C, Wang H, Sternberg SH, , Bacterial genome engineering using CRISPR RNA-guided transposases., bioRxiv 2023 Mar; (): .
• 2022
  Klompe SE, Jaber N, Beh LY, Mohabir JT, Bernheim A, Sternberg SH, Evolutionary and mechanistic diversity of Type I-F CRISPR-associated transposons., Mol Cell 2022 Feb; 82(3): 616-628.e5.
• 2021
  Vo PLH, Ronda C, Klompe SE, Chen EE, Acree C, Wang HH, Sternberg SH, , CRISPR RNA-guided integrases for high-efficiency, multiplexed bacterial genome engineering., Nat Biotechnol 2021 Apr; 39(4): 480-489.
• 2020
  Halpin-Healy TS, Klompe SE, Sternberg SH, Fernández IS, , Publisher Correction: Structural basis of DNA targeting by a transposon-encoded CRISPR-Cas system., Nature 2020 Sep; 585(7825): E12.
• 2020
  Halpin-Healy TS, Klompe SE, Sternberg SH, Fernández IS, , Structural basis of DNA targeting by a transposon-encoded CRISPR-Cas system., Nature 2020 Jan; 577(7789): 271-274.
• 2019
  Cameron P, Coons MM, Klompe SE, Lied AM, Smith SC, Vidal B, Donohoue PD, Rotstein T, Kohrs BW, Nyer DB, Kennedy R, Banh LM, Williams C, Toh MS, Irby MJ, Edwards LS, Lin CH, Owen ALG, Künne T, van der Oost J, Brouns SJJ, Slorach EM, Fuller CK, Gradia S, Kanner SB, May AP, Sternberg SH, , Harnessing type I CRISPR-Cas systems for genome engineering in human cells., Nat Biotechnol 2019 Dec; 37(12): 1471-1477.
• 2019
  Klompe SE, Vo PLH, Halpin-Healy TS, Sternberg SH, , Transposon-encoded CRISPR-Cas systems direct RNA-guided DNA integration., Nature 2019 Jul; 571(7764): 219-225.
• 2018
  Klompe SE, Sternberg SH, , Harnessing “A Billion Years of Experimentation”: The Ongoing Exploration and Exploitation of CRISPR-Cas Immune Systems., CRISPR J 2018 Apr; 1(2): 141-158.